Skip to content

PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

collection

New Tools and Strategies for Tuberculosis Diagnosis, Care, and Elimination

Special Issues

As the leading infectious cause of death worldwide, TB demands an urgent response that will realistically enable its elimination. Despite increases in funding for TB prevention and care in recent years, progress still lags behind targets for the WHO’s End TB strategy. Guest edited by Dr. Claudia Denkinger (FIND), Dr. Richard Chaisson, (Johns Hopkins), and Dr. Mark Hatherill (SATVI), this PLOS Medicine special issue focuses on new approaches to fighting and ending TB, including discovery and validation of novel biomarkers and diagnostic technologies, development of new treatments, testing of vaccines, and implementation studies of new strategies for diagnosis and treatment of TB. 

Image Credit: GDJ, Pixabay and NIAID, Flickr

Guest Editors
  • Image credit
    Richard Chaisson
    Dr. Richard Chaisson
  • Image credit
    Claudia Denkinger
    Dr. Claudia Denkinger
  • Image credit
    Mark Hatherill
    Dr. Mark Hatherill
PLOS Medicine Special Issue
Additional Content
PLOS Channels: Tuberculosis

Channel Editors Dr. Soumya Swaminathan and Dr. Madhukar Pai aim to showcase the most up-to-date research from PLOS journals and across the published literature to assist in the fight against tuberculosis.

Explore the channel
Advances in Clinical Trial Design for Development of New Treatments for Tuberculosis

This PLOS Medicine Special Collection assembles a series of articles on current reflections and describes essential new steps in clinical research that will pave the way for the development of tomorrow’s optimal treatment for all forms of TB.

Explore the collection
Speaking of Medicine Blog

Loading...

Back to top